Insider · CIK 0001441889

Nissenson Allen

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001441889

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.8K sh	—	—	21,750
2026-07-01	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+9,633 sh	—	—	23,892
2025-05-20	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+50K sh	—	—	142,597
2025-05-19	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,900 sh	—	—	7,900
2024-11-21	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2024-05-21	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+36.1K sh	—	—	92,597
2023-12-28	ELTXElicio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2023-05-23	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+24.7K sh	—	—	124,203
2022-06-09	ELTXElicio Therapeutics, Inc. · Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2022-06-07	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+25K sh	—	—	99,488
2022-05-20	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+2,037 sh	$1.18	+$2,403.66	9,383
2022-05-19	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+7,346 sh	$1.16	+$8,521.36	7,346
2021-06-17	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+50K sh	—	—	74,488
2021-06-17	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+72.9K sh	—	—	72,857
2021-03-08	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-12-11	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+1,488 sh	—	—	24,488
2020-06-11	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+23K sh	—	—	23,000
2020-06-11	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+34.6K sh	—	—	34,639
2014-02-13	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+13.2K sh	$23.13	+$305K	16,128
2014-02-13	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−4,591 sh	$66.35	−$305K	11,537
2014-02-13	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−2,547 sh	$66.16	−$169K	8,990
2014-02-13	DVADAVITA INC. · Stock Appreciation RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−13.2K sh	—	—	0
2013-12-17	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,766 sh	$23.13	+$110K	7,274
2013-12-17	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−1,837 sh	$60.02	−$110K	5,437
2013-12-17	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−2,929 sh	$59.83	−$175K	2,508
2013-12-17	DVADAVITA INC. · Stock Appreciation RightsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,766 sh	—	—	13,168
2013-05-13	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,200 sh	$46.26	+$55.5K	2,454
2013-05-13	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−424 sh	$131.19	−$55.6K	2,030
2013-05-13	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−776 sh	$130.37	−$101K	1,254
2013-05-13	DVADAVITA INC. · Stock Appreciation RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,200 sh	—	—	8,967
2013-03-19	DVADAVITA INC. · Stock Appreciation RightA Award	Chief Medical Officer	AAward	+2,000 sh	—	—	2,000
2013-03-19	DVADAVITA INC. · Stock Appreciation RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,000 sh	—	—	2,000
2013-03-06	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,917 sh	$56.14	+$164K	4,171
2013-03-06	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−1,328 sh	$123.35	−$164K	2,843
2013-03-06	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−1,589 sh	$124.00	−$197K	1,254
2013-03-06	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,333 sh	$46.26	+$61.7K	2,587
2013-03-06	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−500 sh	$123.35	−$61.7K	2,087
2013-03-06	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−833 sh	$123.34	−$103K	1,254
2013-03-06	DVADAVITA INC. · Stock Appreciation RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,917 sh	—	—	0
2013-03-06	DVADAVITA INC. · Stock Appreciation RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,333 sh	—	—	10,167
2012-12-18	DVADAVITA INC. · Stock Appreciation RightA Award	Chief Medical Officer	AAward	+750 sh	—	—	750
2012-11-15	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,000 sh	$46.26	+$324K	7,925
2012-11-15	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,890 sh	$112.05	−$324K	5,035
2012-11-15	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−4,110 sh	$112.50	−$462K	925
2012-11-15	DVADAVITA INC. · Stock Appreication RightM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,000 sh	—	—	11,500
2012-08-06	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,917 sh	$56.14	+$164K	3,842
2012-08-06	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−1,650 sh	$99.29	−$164K	2,192
2012-08-06	DVADAVITA INC.S Sale	Chief Medical Officer	SSale	−1,267 sh	$98.72	−$125K	925
2012-08-06	DVADAVITA INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,967 sh	$46.26	+$230K	5,892
2012-08-06	DVADAVITA INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,315 sh	$99.29	−$230K	3,577

Recent filings

Accepted (ET)
Sep 24
Nissenson Allen0001441889-26-000002
SEC(opens sec.gov)
Jul 64
Nissenson Allen0001628280-26-047126
SEC(opens sec.gov)
May 214
Nissenson Allen0001104659-25-051713
SEC(opens sec.gov)
May 204
Nissenson Allen0001601485-25-000089
SEC(opens sec.gov)
Nov 254
Nissenson Allen0001601485-24-000089
SEC(opens sec.gov)
May 234
Nissenson Allen0001104659-24-064810
SEC(opens sec.gov)
Dec 294
Nissenson Allen0001140361-23-060239
SEC(opens sec.gov)
May 254
Nissenson Allen0001104659-23-064638
SEC(opens sec.gov)
Jun 134
Nissenson Allen0001601485-22-000052
SEC(opens sec.gov)
Jun 94
Nissenson Allen0001104659-22-069681
SEC(opens sec.gov)
May 234
Nissenson Allen0001628280-22-015238
SEC(opens sec.gov)
Jun 224
Nissenson Allen0001628280-21-012667
SEC(opens sec.gov)
Mar 104
Nissenson Allen0001567619-21-005970
SEC(opens sec.gov)
Dec 154
Nissenson Allen0001628280-20-017529
SEC(opens sec.gov)
Jun 124
Nissenson Allen0001628280-20-009344
SEC(opens sec.gov)
Feb 184
DAVITA HEALTHCARE PARTNERS INC.0001181431-14-007499
SEC(opens sec.gov)

Companies

Address

C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501

BOSTON, MA, 02210